Why the study?
Does blockade of NF-kappaB activation improve cardiac function and survival in a mouse model of TNF-alpha-induced cardiomyopathy?
Population
Transgenic mice with cardiac-specific overexpression of TNF-alpha (model of cytokine-induced cardiomyopathy)
Comparison
Genetic disruption of the p50 subunit of… vs Transgenic mice with intact p50 subunit of…
Design
Preclinical
Authors
Loading...
p50 disruption benefits TNF-α cardiomyopathy mice via MMP-9; leaves open translation to human heart failure therapy.
Does blockade of NF-kappaB activation improve cardiac function and survival in a mouse model of TNF-alpha-induced cardiomyopathy?
Blockade of NF-κB activation improves cardiac function and survival in a mouse model of TNF-α-induced cardiomyopathy by suppressing MMP-9, suggesting a potential therapeutic target for heart failure.
Kawamura et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: